NEURACEQ is an Imaging/Radiopharmaceutical drug manufactured by Life Molecular Imaging and administered via the Intravenous route of administration. The Q Code: Q9983 is aligned to the drug NEURACEQ.
NEURACEQ – Q9983
read more
Q Code
CEREBYX – Q2009
CEREBYX is an Anti-Convulsant drug manufactured by Pfizer and administered via the Injection route of administration. The Q Code: Q2009 is aligned to the drug CEREBYX.
Integra Bilayer Wound Matrix – Q4104
Integra Bilayer Wound Matrix is a Wound Care drug manufactured by Integra Lifesciences and administered via the Topical application route of administration. The Q Code: Q4104 is aligned to the drug Integra Bilayer Wound Matrix.
Integra Omnigraft Dermal Regeneration Matrix – Q4105
Integra Omnigraft Dermal Regeneration Matrix is a Wound Care drug manufactured by Integra Lifesciences and administered via the Topical application route of administration. The Q Code: Q4105 is aligned to the drug Integra Omnigraft Dermal Regeneration Matrix.
FERAHEME – Q0139
FERAHEME is an Anti-Anemia drug manufactured by Amag Pharmaceuticals and administered via the Intravenous route of administration. The Q Code: Q0139 is aligned to the drug FERAHEME.
FERAHEME – Q0138
FERAHEME is an Anti-Anemia drug manufactured by Amag Pharmaceuticals and administered via the Intravenous route of administration. The Q Code: Q0138 is aligned to the drug FERAHEME.
Alymsys – Q5126
Alymsys is an Oncology drug manufactured by Amneal Biosciences and administered via the Intravenous route of administration. The Q Code: Q5126 is aligned to the drug Alymsys.
YESCARTA – Q2041
YESCARTA is an Oncology drug manufactured by Kite Pharma and administered via the Intravenous route of administration. The Q Code: Q2041 is aligned to the drug YESCARTA.
TENIPOSIDE – Q2017
TENIPOSIDE is an Oncology drug manufactured by WG Critical Care and administered via the Intravenous route of administration. The Q Code: Q2017 is aligned to the drug TENIPOSIDE.
ACTEMRA – Q0249
ACTEMRA is a COVID-19 drug manufactured by Genentech and administered via the Intravenous route of administration. The Q Code: Q0249 is aligned to the drug ACTEMRA.
Sotrovimab Injection – Q0247
Sotrovimab Injection is a COVID-19 drug manufactured by GSK and administered via the Intravenous route of administration. The Q Code: Q0247 is aligned to the drug Sotrovimab Injection.
BEBTELOVIMAB – Q0222
BEBTELOVIMAB is a COVID-19 drug manufactured by Eli Lilly and Company and administered via the Intravenous route of administration. The Q Code: Q0222 is aligned to the drug BEBTELOVIMAB.